Technical Analysis for NVCR - NovoCure Limited
Grade | Last Price | % Change | Price Change |
---|---|---|---|
C | 16.86 | 2.31% | 0.38 |
NVCR closed up 2.31 percent on Wednesday, November 20, 2024, on 67 percent of normal volume. The stock rose above its 50 day moving average, improving its intermediate-term outlook by crossing above that important trendline. Its advance stalled at its 200 day moving average, an important long-term support / resistance line.
ADX | Long Term | Intermediate Term | Short Term |
---|---|---|---|
Weak or Absent | Down | Up | Down |
Date | Alert Name | Type | % Chg |
---|---|---|---|
200 DMA Resistance | Bearish | 0.00% | |
Crossed Above 20 DMA | Bullish | 0.00% | |
Crossed Above 50 DMA | Bullish | 0.00% | |
Bollinger Band Squeeze | Range Contraction | 0.00% | |
50 DMA Resistance | Bearish | 2.31% | |
Bullish Engulfing | Bullish | 2.31% | |
Bollinger Band Squeeze | Range Contraction | 2.31% | |
Outside Day | Range Expansion | 2.31% | |
Bollinger Band Squeeze | Range Contraction | 7.18% | |
NR7 | Range Contraction | 7.18% |
Alert | Time |
---|---|
20 DMA Resistance | about 20 hours ago |
200 DMA Resistance | about 21 hours ago |
10 DMA Resistance | about 21 hours ago |
Up 5% | about 21 hours ago |
Rose Above 200 DMA | about 21 hours ago |
Get a Trading Sidekick!
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 11/01/2024
NovoCure Limited develops and commercializes treatment for solid tumor cancers therapy called the tumor treating fields (TTFields). The company markets its proprietary therapy, TTFields delivery system under the Optune name for use as a monotherapy treatment for adult patients with glioblastoma brain cancer. NovoCure Limited also conducts clinical trials for the use of TTFields in brain metastases, advanced non-small cell lung cancer, pancreatic cancer, ovarian cancer, and mesothelioma. The company markets its products in the United States, as well as in European Union member states, Switzerland, and Japan. NovoCure Limited was founded in 2000 and is based in Saint Helier, Channel Islands.
Sector: Healthcare
Industry: Medical Instruments & Supplies
Keywords: Medicine Cancer Clinical Medicine Oncology Tumor Non Small Cell Lung Cancer Ovarian Cancer Pancreatic Cancer Small Cell Lung Cancer Blastoma Glioblastoma Brain Tumor Solid Tumor Cancers Aging Associated Diseases Brain Cancer Metastases Mesothelioma
Classification
Sector: Healthcare
Industry: Medical Instruments & Supplies
Keywords: Medicine Cancer Clinical Medicine Oncology Tumor Non Small Cell Lung Cancer Ovarian Cancer Pancreatic Cancer Small Cell Lung Cancer Blastoma Glioblastoma Brain Tumor Solid Tumor Cancers Aging Associated Diseases Brain Cancer Metastases Mesothelioma
Indicator | Bull Case | Neutral / Hold | Bear Case |
---|---|---|---|
50 DMA | |||
200 DMA | |||
ADX Trend | |||
Oversold / Overbought | |||
Relative Strength |
Indicator | Value |
---|---|
52 Week High | 24.735 |
52 Week Low | 11.31 |
Average Volume | 1,008,397 |
200-Day Moving Average | 17.10 |
50-Day Moving Average | 16.52 |
20-Day Moving Average | 16.85 |
10-Day Moving Average | 17.07 |
Average True Range | 1.08 |
RSI (14) | 50.74 |
ADX | 19.34 |
+DI | 26.92 |
-DI | 19.52 |
Chandelier Exit (Long, 3 ATRs) | 15.42 |
Chandelier Exit (Short, 3 ATRs) | 18.35 |
Upper Bollinger Bands | 18.40 |
Lower Bollinger Band | 15.30 |
Percent B (%b) | 0.5 |
BandWidth | 18.43 |
MACD Line | 0.04 |
MACD Signal Line | 0.13 |
MACD Histogram | -0.097 |
Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
---|---|---|---|---|---|
Resistance 4 (R4) | 18.56 | ||||
Resistance 3 (R3) | 18.53 | 17.94 | 18.27 | ||
Resistance 2 (R2) | 17.94 | 17.51 | 17.95 | 18.18 | |
Resistance 1 (R1) | 17.40 | 17.24 | 17.67 | 17.43 | 18.08 |
Pivot Point | 16.81 | 16.81 | 16.95 | 16.82 | 16.81 |
Support 1 (S1) | 16.27 | 16.38 | 16.54 | 16.30 | 15.64 |
Support 2 (S2) | 15.68 | 16.11 | 15.69 | 15.54 | |
Support 3 (S3) | 15.14 | 15.68 | 15.45 | ||
Support 4 (S4) | 15.17 |